Brisbois Ben W, Cole Donald C, Davison Colleen M, Di Ruggiero Erica, Hanson Lori, Janes Craig R, Larson Charles P, Nixon Stephanie, Plamondon Katrina, Stime Bjorn
Postdoctoral Fellow, Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON.
Can J Public Health. 2016 Dec 27;107(4-5):e390-e392. doi: 10.17269/cjph.107.5653.
Funding options for global health research prominently include grants from corporations, as well as from foundations linked to specific corporations. While such funds can enable urgently-needed research and interventions, they can carry the risk of skewing health research priorities and exacerbating health inequities. With the objective of promoting critical reflection on potential corporate funding options for global health research, we propose a set of three questions developed through an open conference workshop and reflection on experiences of global health researchers and their institutions: 1) Does this funding allow me/us to retain control over research design, methodology and dissemination processes? 2) Does accessing this funding source involve altering my/our research agenda (i.e., what is the impact of this funding source on research priorities)? 3) What are the potential "unintended consequences" of accepting corporate funding, in terms of legitimizing corporations or models of development that are at the root of many global health problems? These questions outline an intentional and cautionary approach to decision-making when corporate funding for global health research is being considered by funding agencies, institutions, researchers and research stakeholders.
全球卫生研究的资金来源主要包括企业提供的资助,以及与特定企业相关的基金会提供的资助。虽然这些资金能够推动开展急需的研究和干预措施,但也可能存在扭曲卫生研究重点以及加剧卫生不公平现象的风险。为了促进对全球卫生研究潜在企业资金来源进行批判性思考,我们提出了一组通过公开会议研讨会以及对全球卫生研究人员及其机构的经验进行反思而形成的三个问题:1)这笔资金是否能让我/我们保持对研究设计、方法和传播过程的控制权?2)获取这笔资金来源是否会导致我/我们改变研究议程(即,这笔资金来源对研究重点有何影响)?3)就使那些构成许多全球卫生问题根源的企业或发展模式合法化而言,接受企业资金的潜在“意外后果”是什么?当资助机构、机构、研究人员和研究利益相关者考虑为全球卫生研究提供企业资金时,这些问题勾勒出了一种有意且谨慎的决策方法。